Pharmaceutical Social Media – the dos and don’ts from a Medical Compliance perspectivePublished: July 5, 2022
Another milestone reached for AlzeCure’s Phase II clinical trial in neuropathic pain with non-opioid ACD440Published: June 22, 2022
LINK Medical, the Northern European CRO has raised capital to fund further growthPublished: May 2, 2022
Closing the gap between developers and users results in a unique eTMF solutionPublished: April 20, 2022
